Albumin conjugation
The DAC group binds serum albumin, the property that separates this compound from every other GHRH fragment in the catalog.
These are results measured on this lot. Full material specification is in Know your compound.
Long-Acting GHRH Analog
A GHRH analog carrying a Drug Affinity Complex for extended plasma exposure.
$22.50 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
CJC-1295 DAC is the same 29-residue GHRH analog as the standard form, with one significant addition: a Drug Affinity Complex — a maleimidoproprionic acid group — that binds covalently to circulating serum albumin after administration.
That albumin binding is what defines the molecule. Because albumin has a multi-day circulating half-life, the conjugated peptide is protected from renal clearance and enzymatic degradation, and the published literature describes an exposure profile measured in days rather than minutes. Research comparing the DAC and non-DAC forms is the clearest illustration in this class of how a single conjugation changes pharmacokinetics without changing the receptor target.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
The DAC group binds serum albumin, the property that separates this compound from every other GHRH fragment in the catalog.
Literature characterises a substantially longer half-life than the non-DAC form, driven by protection from renal clearance.
The receptor target remains the GHRH receptor; the conjugation alters duration, not selectivity.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-047
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. CJC-1295 DAC is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.